Suba Chandra

Suba Chandra currently serves as a Regulatory Specialist at a leading skincare, OTC, and pharmaceutical company, where she plays a pivotal role in ensuring the seamless compliance of a diverse portfolio of products with global regulatory standards. Her expertise encompasses a broad spectrum of regulatory affairs activities, including reviewing product labeling for accuracy, clarity, and legal compliance, and providing strategic regulatory guidance across departments such as operations, medical affairs, and commercial teams. Suba’s deep understanding of regulatory frameworks within the pharmaceutical and cosmetology sectors enables her to navigate complex regulatory landscapes, particularly within the European Union and other key markets.

In her current role, Suba has led several key projects focused on regulatory submissions for new product launches, ensuring timely approval and market entry. She has also been instrumental in conducting comprehensive regulatory assessments, which involve evaluating product safety profiles, pharmacology data, and quality control measures to ensure adherence to evolving industry standards. Her proficiency in reviewing and developing product labeling aligns with her commitment to maintaining transparency and compliance, ultimately safeguarding consumer trust and brand integrity.

With over six years of experience in the pharmaceutical industry, Suba has cultivated a robust skill set that includes pharmacology, pathophysiology, and quality control, complemented by her ability to communicate complex regulatory information effectively. Her expertise in regulatory development and submissions, combined with her proficiency in tools like PowerPoint and Windows, allows her to prepare detailed documentation and presentations that support regulatory decision-making. Suba’s dedication to staying current with industry regulations and her collaborative approach make her a valuable asset in advancing her organization’s compliance and product development goals in the competitive skincare and OTC markets.